SpyGlass Pharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -341 | -318 | -216 | |
EBITDA | -21,626 | -13,500 | -12,338 | -10,964 |
EBIT | -21,967 | -13,818 | -12,555 | -11,101 |
Net Income | -19,864 | -13,818 | -12,555 | -9,815 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -16,771 | -14,220 | -9,754 | -8,993 |
Cash | 223,143 | 238,902 | 96,358 | 106,006 |
Basic Shares | 33,439 | 19,927 | 33,426 | 33,426 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -612 | ||
EBITDA | -39,257 | -26,793 | -14,107 |
EBIT | -39,869 | -27,064 | -14,230 |
Net Income | -39,869 | -29,164 | -13,318 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -33,490 | -24,018 | -12,494 |
Cash | 96,358 | 16,268 | 15,848 |
Basic Shares | 31,911 | 31,911 | 31,911 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.59 |
2026-03-31 | -$0.69 |
2025-12-31 | -$0.37 |